NCT02585453View on ClinicalTrials.gov

Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye Syndrome

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

November 30, 2015

Conditions

Dry Eye Syndromes

Interventions

DEVICE

Thealoz Duo Gel

Manufacturer: Laboratoires Thea, France

DEVICE

Hylo-Gel

Manufacturer: Ursapharm, Saarbrücken, Germany

DEVICE

Systane Gel Drops

Manufacturer: Alcon Pharma GmbH, Fort Worth, TX, USA

Trial Locations (1)

1090

Department of Clinical Pharmacology, Medical University of Vienna, Vienna

All Listed Sponsors

lead

Medical University of Vienna

OTHER

NCT02585453 - Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye Syndrome | Biotech Hunter | Biotech Hunter